Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Matsuda

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|October 12, 2022
Long-term follow-up of central nervous system relapse in patients with acute promyelocytic leukemia treated with all-<i>trans</i> retinoic acid and chemotherapyTakashi Oyama, Kensuke Matsuda, Akira Honda, et al.
Internal Medicine (Tokyo, Japan)|December 8, 2022
Prompt Initiation of Conventional Chemotherapy to Avoid Early Death in Patients with Newly Diagnosed Acute Promyelocytic LeukemiaKensuke Matsuda, Takashi Oyama, Hiroaki Maki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 23, 2021
Use of wide-spectrum antimicrobials with blood culture tests during chemotherapy as an accurate marker of febrile neutropenia in the DPC database: A validation studyKensuke Matsuda, Masataka Ise, Arika Shimura, et al.
Annals of Hematology|November 4, 2017
Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective studyKensuke Matsuda, Kazuki Taoka, Masahiro Jona, et al.
Annals of Hematology|July 26, 2021
Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in JapanKensuke Matsuda, Taisuke Jo, Kazuhiro Toyama, et al.
Internal Medicine (Tokyo, Japan)|May 31, 2023
Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the LiteratureYasutaka Masuda, Takashi Oyama, Kumi Nakazaki, et al.
Cureus|April 22, 2026
Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective StudyNobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 22, 2021
Difference of preventing effects of G-CSF according to age in patients with malignant lymphoma: A nation-wide analysis in JapanKensuke Matsuda, Taisuke Jo, Masashi Miyauchi, et al.
Leukemia & Lymphoma|June 13, 2020
Primary prophylaxis with pegfilgrastim in patients with newly-diagnosed diffuse large B-cell lymphoma: propensity score and instrumental variable analysesKensuke Matsuda, Jo Taisuke, Masashi Miyauchi, et al.
Hematological Oncology|May 2, 2021
Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomasToshiaki Takezaki, Kumi Nakazaki, Kazuhiro Toyama, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|October 12, 2022
Long-term follow-up of central nervous system relapse in patients with acute promyelocytic leukemia treated with all-<i>trans</i> retinoic acid and chemotherapyTakashi Oyama, Kensuke Matsuda, Akira Honda, et al.
Internal Medicine (Tokyo, Japan)|December 8, 2022
Prompt Initiation of Conventional Chemotherapy to Avoid Early Death in Patients with Newly Diagnosed Acute Promyelocytic LeukemiaKensuke Matsuda, Takashi Oyama, Hiroaki Maki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 23, 2021
Use of wide-spectrum antimicrobials with blood culture tests during chemotherapy as an accurate marker of febrile neutropenia in the DPC database: A validation studyKensuke Matsuda, Masataka Ise, Arika Shimura, et al.
Annals of Hematology|November 4, 2017
Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective studyKensuke Matsuda, Kazuki Taoka, Masahiro Jona, et al.
Annals of Hematology|July 26, 2021
Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in JapanKensuke Matsuda, Taisuke Jo, Kazuhiro Toyama, et al.
Internal Medicine (Tokyo, Japan)|May 31, 2023
Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the LiteratureYasutaka Masuda, Takashi Oyama, Kumi Nakazaki, et al.
Cureus|April 22, 2026
Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective StudyNobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 22, 2021
Difference of preventing effects of G-CSF according to age in patients with malignant lymphoma: A nation-wide analysis in JapanKensuke Matsuda, Taisuke Jo, Masashi Miyauchi, et al.
Leukemia & Lymphoma|June 13, 2020
Primary prophylaxis with pegfilgrastim in patients with newly-diagnosed diffuse large B-cell lymphoma: propensity score and instrumental variable analysesKensuke Matsuda, Jo Taisuke, Masashi Miyauchi, et al.
Hematological Oncology|May 2, 2021
Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomasToshiaki Takezaki, Kumi Nakazaki, Kazuhiro Toyama, et al.
Pageof 6